Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pronova prices IPO

Pronova (OSE:PRON) raised NOK575 million ($106.3 million) through the sale of 25

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE